IR Pro
Strategy
IR Pro
Can Novo win the weight-loss war with Eli Lilly?
Strong early demand for Novo’s oral Wegovy is promising, but investors want proof it can offset price pressure and rising competit...
Get the latest from Inside Retail straight to your inbox.
Join over 100,000 retailers who rely on our daily news, views and intelligence - it's free.